MedTrace Logo

Ventricular Assist Device (VAD) Research Registry and Blood Sub-Study

NCT05637242 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 371

Last updated 2024-06-05

No results posted yet for this study

Summary

This study is meant to predict the outcome of VAD therapy, by forming a VAD registry for quality assessment, research, and real-time monitoring of patients on VAD therapy. The goal is to optimize the use of VAD therapy for patients, to create an online quality measurement tool for VAD treatment, and to create algorithms to estimate the prognosis for patients getting a VAD.

Conditions

Sponsors & Collaborators

  • Spectrum Health Hospitals

    lead OTHER

Principal Investigators

  • Renzo Loyaga, MD PhD · The DeVos Cardiovascular Research Program, Frederik Meijer Heart & Vascular Institute, Corewell Health

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-02-29
Primary Completion
2021-10-13
Completion
2024-05-29

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05637242 on ClinicalTrials.gov